Stolper & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.65M | Sell |
14,264
-46
| -0.3% | -$8.54K | 0.87% | 33 |
|
2025
Q1 | $3M | Sell |
14,310
-196
| -1% | -$41.1K | 0.98% | 31 |
|
2024
Q4 | $2.58M | Buy |
14,506
+68
| +0.5% | +$12.1K | 0.86% | 33 |
|
2024
Q3 | $2.85M | Sell |
14,438
-64
| -0.4% | -$12.6K | 0.93% | 31 |
|
2024
Q2 | $2.49M | Sell |
14,502
-32
| -0.2% | -$5.49K | 0.88% | 32 |
|
2024
Q1 | $2.65M | Buy |
14,534
+19
| +0.1% | +$3.46K | 0.95% | 32 |
|
2023
Q4 | $2.25M | Sell |
14,515
-216
| -1% | -$33.5K | 0.91% | 31 |
|
2023
Q3 | $2.2M | Sell |
14,731
-123
| -0.8% | -$18.3K | 0.95% | 32 |
|
2023
Q2 | $2M | Sell |
14,854
-128
| -0.9% | -$17.2K | 0.84% | 34 |
|
2023
Q1 | $2.39M | Sell |
14,982
-98
| -0.6% | -$15.6K | 1.02% | 31 |
|
2022
Q4 | $2.44M | Sell |
15,080
-3,469
| -19% | -$561K | 1.07% | 30 |
|
2022
Q3 | $2.49M | Buy |
18,549
+927
| +5% | +$124K | 1.23% | 29 |
|
2022
Q2 | $2.7M | Sell |
17,622
-710
| -4% | -$109K | 1.27% | 27 |
|
2022
Q1 | $2.97M | Buy |
18,332
+350
| +2% | +$56.7K | 1.26% | 26 |
|
2021
Q4 | $2.44M | Buy |
17,982
+5
| +0% | +$677 | 1.09% | 29 |
|
2021
Q3 | $1.94M | Buy |
17,977
+197
| +1% | +$21.2K | 0.93% | 34 |
|
2021
Q2 | $2M | Buy |
17,780
+112
| +0.6% | +$12.6K | 0.94% | 31 |
|
2021
Q1 | $1.91M | Sell |
17,668
-171
| -1% | -$18.5K | 0.98% | 30 |
|
2020
Q4 | $1.91M | Buy |
17,839
+273
| +2% | +$29.2K | 1.07% | 29 |
|
2020
Q3 | $1.54M | Sell |
17,566
-3,044
| -15% | -$267K | 0.99% | 32 |
|
2020
Q2 | $2.02M | Sell |
20,610
-1,549
| -7% | -$152K | 1.32% | 27 |
|
2020
Q1 | $1.69M | Buy |
+22,159
| New | +$1.69M | 1.21% | 29 |
|